Dechra Pharmaceuticals (DPH)
DPH Share PerformanceMore
|52 week high||2,199.0 03/11/17|
|52 week low||1,225.0 09/12/16|
|52 week change||841.0 (65.50%)|
|4 week volume||2,484,443 24/10/17|
Media for (DPH)
Latest News« previous» nextMore
31/10/2017 - 12:07 RNS
RNS Number: 1204V Dechra Pharmaceuticals PLC 31 October 2017 31 October 2017 Dechra Pharmaceuticals PLC (Dechra or the Company) LEI: 213800J4UVB5OWG8VX82 Total Voting Rights In conformity with DTR 5.6.1R, the Company notifies the market of the following: As at the date of this announcement, the Company's issued share capital consists of 93,415,750...
20/10/2017 - 13:35 RNS
RNS Number: 2365U Dechra Pharmaceuticals PLC 20 October 2017 Date: 20 October 2017 Dechra Pharmaceuticals PLC Results of Annual General Meeting (AGM) AGM Meeting Date: 1pm on 20 October 2017 Issued Share Capital at meeting date: 93,415,750 Number of shareholders in attendance: 12 All resolutions were passed on a show of hands. Details of the proxy v...
20/10/2017 - 11:05 Interactive Investor
Two top fund managers tell David Brenchley about their favourite small and mid-cap companies as they rotate out of UK...
20/10/2017 - 06:06 StockMarketWire
Dechra Pharmaceuticals' performance in the first quarter was in line with management expectations, with continued grow...
20/10/2017 - 06:00 RNS
RNS Number: 1377U Dechra Pharmaceuticals PLC 20 October 2017 Friday, 20 October 2017 Dechra Pharmaceuticals PLC (Dechra or the Company) Pre Annual General Meeting Statement The Board of Dechra issues the following trading update prior to the Annual General Meeting (AGM) which will take place at 1.00pm today, Friday 20 October 2017, at The Mere H...
18/10/2017 - 07:57 RNS
RNS Number: 9313T Dechra Pharmaceuticals PLC 18 October 2017 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: Dechra P...
12/10/2017 - 11:15 RNS
RNS Number: 4638T Dechra Pharmaceuticals PLC 12 October 2017 12 October 2017 Dechra Pharmaceuticals PLC (Dechra or the Company) LEI: 213800J4UVB5OWG8VX82 Notification and public disclosure of transactions by persons discharging managerial responsibilities (PDMRs) Grant of SAYE options: Dechra Pharmaceuticals PLC announces that today the foll...
12/10/2017 - 09:39 RNS
RNS Number: 4416T Dechra Pharmaceuticals PLC 12 October 2017 12 October 2017 Dechra Pharmaceuticals PLC (Dechra or the Company) Additional Listing An application has been made to the Financial Conduct Authority and the London Stock Exchange for a total of 80,000 ordinary shares of 1 pence each (the "Shares") to be admitted to the Official List. These S...
|Dividend yield||1.009 %|
Latest discussion posts More
“.....telling clients to buy .....target #22 .new suit for xmas if they hit this target !!”▼
“That sounds positive Valeite. I think that this one may be a bit volatile as the valuation is so high that any bit of negative news could cause an exaggerated fall. From ...”▼
“price target #21.56”▼
Codes & Symbols
|Symbols||DPH, LSE:DPH, DPH.L, DPH:LN, LON:DPH, XLON:DPH|
Join interactive investor
- £22.50 fixed quarterly charge includes £22.50 in trading credits
- £10 per trade or £6 for frequent traders
- No % platform fees
- £1 per trade for regular investment or dividend reinvestment